SCYNEXIS, Inc. (SCYX)
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
$59.06M
Mr. David Gonzalez Angulo M.D.
56.00
Jersey City, NJ
May 02, 2014
-2.11
$-0.74
3.58
9.01
13.09%
7.61%
7.64
0.19
0.85
0.45
8.18
6.67%
49.42%
Similar stocks (14)
ANI Pharmaceuticals, Inc.
ANIP
Phibro Animal Health Corporation
PAHC
Ironwood Pharmaceuticals, Inc.
IRWD
Pacira BioSciences, Inc.
PCRX
Organogenesis Holdings Inc.
ORGO
Alimera Sciences, Inc.
ALIM
Alpha Teknova, Inc.
TKNO
Lifecore Biomedical, Inc.
LFCR
Silver Spike Investment Corp.
SSIC
Eagle Pharmaceuticals, Inc.
EGRX
Cumberland Pharmaceuticals Inc.
CPIX
Guardion Health Sciences, Inc.
GHSI
Biofrontera Inc.
BFRI
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
ETF Exposure (12)
iShares Micro-Cap ETF
IWC
0.01378%
Dimensional U.S. Core Equity 2 ETF
DFAC
2.367e-5%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (14)
ANI Pharmaceuticals, Inc.
ANIP
Phibro Animal Health Corporation
PAHC
Ironwood Pharmaceuticals, Inc.
IRWD
Pacira BioSciences, Inc.
PCRX
Organogenesis Holdings Inc.
ORGO
Alimera Sciences, Inc.
ALIM
Alpha Teknova, Inc.
TKNO
Lifecore Biomedical, Inc.
LFCR
Silver Spike Investment Corp.
SSIC
Eagle Pharmaceuticals, Inc.
EGRX
Cumberland Pharmaceuticals Inc.
CPIX
Guardion Health Sciences, Inc.
GHSI
Biofrontera Inc.
BFRI
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
ETF Exposure (12)
iShares Micro-Cap ETF
IWC
0.01378%
Dimensional U.S. Core Equity 2 ETF
DFAC
2.367e-5%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%